Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Clinical Rheumatology
|
July 26, 2017
The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients
Jiangfeng Zhao, Kaiwen Wang, Xiaodong Wang, et al.
Respiratory Research
|
November 12, 2023
Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression
Jie Zhou, Peiwei Li, Xiaogang Zhao, et al.
Rheumatology (Oxford, England)
|
December 4, 2018
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease
Kaiwen Wang, Jiangfeng Zhao, Zhiwei Chen, et al.
The European Respiratory Journal
|
January 30, 2025
Effectiveness and safety of tofacitinib <i>versus</i> calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study
Wanlong Wu, Bingpeng Guo, Wenjia Sun, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Clinical Rheumatology
|
July 26, 2017
The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients
Jiangfeng Zhao, Kaiwen Wang, Xiaodong Wang, et al.
Respiratory Research
|
November 12, 2023
Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression
Jie Zhou, Peiwei Li, Xiaogang Zhao, et al.
Rheumatology (Oxford, England)
|
December 4, 2018
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease
Kaiwen Wang, Jiangfeng Zhao, Zhiwei Chen, et al.
The European Respiratory Journal
|
January 30, 2025
Effectiveness and safety of tofacitinib <i>versus</i> calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study
Wanlong Wu, Bingpeng Guo, Wenjia Sun, et al.
Page
of 3